Ecstasy (MDMA) exposure and neuropsychological functioning: A polydrug perspective
- 21 October 2005
- journal article
- research article
- Published by Cambridge University Press (CUP) in Journal of the International Neuropsychological Society
- Vol. 11 (06) , 753-765
- https://doi.org/10.1017/s1355617705050915
Abstract
Ecstasy (MDMA) is a popular drug that can act as a selective serotonin neurotoxin in several species. The goal of the present study was to examine the relationship between ecstasy exposure and cognitive functioning after controlling for other drug use and demographic variables. Furthermore, we assessed whether gender was a moderator of the relationship between cognitive functioning and ecstasy use. Data were collected from 31 men and 34 women with a wide range of ecstasy use (17 marijuana users with no ecstasy use and 48 ecstasy users ranging from low to heavy use). Participants were interviewed and administered a battery of neuropsychological tests. The primary finding was that ecstasy exposure was significantly related to poorer verbal learning and memory ability in a dose-dependent manner, while no such relationship was observed between ecstasy exposure and executive functioning or attentional ability. Gender was found to significantly moderate the relationship between ecstasy consumption and design fluency. These results suggest primary memory dysfunction among abstinent recreational ecstasy users. This finding is consistent with reports of hippocampal vulnerability, particularly among heavy users. (JINS, 2005, 11, 753–765.)Keywords
This publication has 47 references indexed in Scilit:
- Specific memory deficits in ecstasy users? The results of a meta‐analysisHuman Psychopharmacology: Clinical and Experimental, 2003
- The Acute and Chronic Effects of MDMA (“Ecstasy”) on Cortical 5-HT2A Receptors in Rat and Human BrainNeuropsychopharmacology, 2002
- Auditory verbal learning in drug‐free Ecstasy polydrug usersHuman Psychopharmacology: Clinical and Experimental, 2001
- Functional Consequences of Repeated (±)3,4-Methylenedioxymethamphetamine (MDMA) Treatment in Rhesus MonkeysNeuropsychopharmacology, 2001
- No Difference in Brain Activation During Cognitive Performance Between Ecstasy (3,4-Methylenedioxymethamphetamine) Users and Control Subjects: A [H215O]-Positron Emission Tomography StudyJournal of Clinical Psychopharmacology, 2001
- (±)3,4-Methylenedioxymethamphetamine (‘Ecstasy’)-Induced Serotonin Neurotoxicity: Clinical StudiesNeuropsychobiology, 2000
- Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug usersDrug and Alcohol Dependence, 2000
- Demographically Corrected Norms for the California Verbal Learning TestJournal of Clinical and Experimental Neuropsychology, 2000
- Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptorsNeuropharmacology, 1992
- Chronic 3,4-Methylenedioxymethamphetamine (MDMA) Use: Effects on Mood and Neuropsychological Function?The American Journal of Drug and Alcohol Abuse, 1992